Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival

Medical-technology companies are helping revive initial public offerings in the life-sciences sector in the US after a tough year so far, during which regulatory uncertainty has hampered such activity.

Shoulder Innovations Inc., a commercial-stage shoulder surgery implant maker, is on track to price an IPO raising as much as $105 million late Wednesday. That makes it the second medical-devices company to go public in a week, following the debut of spinal-surgery implant market Carlsmed Inc. last Wednesday. Shoulder’s offering has attracted demand for multiple times the available shares, including sizable anchor orders from mutual funds, Bloomberg reported earlier ...